Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02638103
Brief Title: Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of Migraine (HALO)

First Submitted : December 18, 2015
First Submitted that Met QC Criteria : December 18, 2015
First Posted : December 22, 2015 (Estimate)

Results First Submitted : June 5, 2019
Results First Submitted that Met QC Criteria : August 12, 2019
Results First Posted : August 28, 2019

Last Update Submitted that Met QC Criteria : February 17, 2020
Last Update Posted : February 28, 2020